article thumbnail

Exendin?4: A potential therapeutic strategy for Alzheimer's disease and Parkinson's disease

Chemical Biology and Drug Design

The figure depicts the neuroprotective role of exendin-4 in Alzheimer's disease and Parkinson's disease. Exendin-4's diverse therapeutic targets suggest its potential therapeutic uses in neurodegenerative ailments like Alzheimer's disease and Parkinson's disease and have garnered an increasing amount of attention.

Disease 189
article thumbnail

How is Parkinson’s disease diagnosed?

Antidote

Parkinson’s disease symptoms can vary from person to person. In this blog, we’ll be sharing more details about the disease and discussing opportunities for individuals to get involved in Parkinson’s research. Receiving a Parkinson’s diagnosis is a life-altering event that nearly 1 million people in the United States have experienced.

Disease 114
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Prevent Fungal Diseases in the Workplace

NIOSH Science Blog: Drugs

As part of Fungal Disease Awareness Week, we are highlighting fungal diseases that can affect workers. Coccidioidomycosis (Valley fever), blastomycosis, and histoplasmosis are fungal diseases caused by fungi that live in the environment in certain regions. Fungal diseases to watch out for Coccidioidomycosis, or

Disease 97
article thumbnail

Recent Advances in Medicinal Chemistry of Memantine Against Alzheimer's Disease

Chemical Biology and Drug Design

Alzheimer's disease (AD) is a progressive age-related neurodegenerative disorder characterized by loss of memory and other cognitive functions. The problem of this disease is even more fundamental because the available therapies only provide symptomatic relief without addressing the basic factor of the disease.

Disease 100
article thumbnail

The Evolving Alzheimer’s Disease Landscape

Fierce BioTech

Alzheimer’s disease research and drug development is evolving at a rapid pace. Decades of research has led to the approval of the first disease-modifying drugs and new pathological discoveries. |

Disease 116
article thumbnail

Parkinson's Disease: New theory on the disease's origins and spread

Science Daily: Pharmacology News

New hypothesis paper builds on a growing scientific consensus that Parkinson's disease route to the brain starts in either the nose or the gut and proposes that environmental toxicants are the likely source.

Disease 144
article thumbnail

AI Uses Zero-Shot Learning to Find Existing Drugs for Treating Rare Diseases

Nvidia Developer: Drug Discovery

A groundbreaking drug-repurposing AI model could bring new hope to doctors and patients trying to treat diseases with limited or no existing treatment options. A groundbreaking drug-repurposing AI model could bring new hope to doctors and patients trying to treat diseases with limited or no existing treatment options.

Disease 145